deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT02506985

XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis (XENITH)

Sponsor: Janssen Scientific Affairs, LLC

Conditions Pulmonary Embolism Venous Thrombosis
Interventions rivaroxaban warfarin
Updated 9 times since 2017 Last updated: Aug 30, 2018 Started: Jul 31, 2015 Primary completion: Jun 29, 2016 Completion: Jun 29, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Janssen Scientific Affairs, LLC

More terminations from Janssen Scientific Affairs, LLC

Other Pulmonary Embolism trials with similar outcome

Browse all Pulmonary Embolism trials

Listed as NCT02506985, this PHASE4 trial focuses on Pulmonary Embolism and Venous Thrombosis and remains terminated or withdrawn. Sponsored by Janssen Scientific Affairs, LLC, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotTerminated~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE4

▶ Show 4 earlier versions

  1. Oct 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  2. Jun 2018 — Oct 2018 [monthly]

    Terminated PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Janssen Scientific Affairs, LLC
  • Susan Smyth
Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.